Case Study

Cell Culture Titer & Protein Quality

GE i zZBdtQg

The requirements for speed and economy are climbing in the biopharma industry. Go/no go decisions are being made earlier, and products need to be brought to market faster and at a better price point. These needs translate into increasing pressure to quickly create processes that are cost-effective at manufacturing scale. Gains in protein productivity can cumulatively make a real positive impact on your process economy.

When evaluating media with the goal of increasing titers, it is important to ensure that protein quality is not negatively impacted. So how can this process improvement be performed reliably? It makes sense to use a Design of Experiment (DoE) and empirical approach. Here is an example of how to do it.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Biosimilar Development? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: